News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
613,992 Results
Type
Article (53077)
Company Profile (319)
Press Release (560596)
Section
Business (169735)
Career Advice (2435)
Deals (31015)
Drug Delivery (113)
Drug Development (79244)
Employer Resources (150)
FDA (16430)
Job Trends (13393)
News (304214)
Policy (32137)
Tag
Academia (2675)
Alliances (43935)
Alzheimer's disease (1358)
Approvals (16341)
Artificial intelligence (148)
Bankruptcy (316)
Best Places to Work (10478)
Biotechnology (212)
Breast cancer (190)
Cancer (1378)
Cardiovascular disease (118)
Career advice (2034)
Cell therapy (293)
Clinical research (63045)
Collaboration (447)
Compensation (250)
COVID-19 (2719)
C-suite (112)
Data (1365)
Diabetes (172)
Diagnostics (6014)
Drug pricing (105)
Earnings (64604)
Employer resources (138)
Events (92217)
Executive appointments (354)
FDA (17075)
Funding (399)
Gene therapy (216)
GLP-1 (691)
Government (4306)
Healthcare (17057)
Infectious disease (2818)
Inflammatory bowel disease (125)
Interviews (448)
IPO (15146)
Job creations (3362)
Job search strategy (1703)
Layoffs (467)
Legal (7314)
Lung cancer (201)
Manufacturing (200)
Medical device (12098)
Medtech (12101)
Mergers & acquisitions (16002)
Metabolic disorders (484)
Neuroscience (1703)
NextGen Class of 2024 (5782)
Non-profit (4434)
Northern California (1616)
Obesity (283)
Opinion (202)
Patents (121)
People (49584)
Phase I (19257)
Phase II (27629)
Phase III (21294)
Pipeline (515)
Postmarket research (2628)
Preclinical (8140)
Radiopharmaceuticals (226)
Rare diseases (281)
Real estate (4894)
Regulatory (22011)
Research institute (2431)
Resumes & cover letters (407)
Southern California (1374)
Startups (3284)
United States (14329)
Vaccines (653)
Weight loss (222)
Date
Today (89)
Last 7 days (673)
Last 30 days (2708)
Last 365 days (34882)
2024 (34016)
2023 (39047)
2022 (49933)
2021 (53851)
2020 (51465)
2019 (41908)
2018 (31781)
2017 (31573)
2016 (30472)
2015 (34220)
2014 (27052)
2013 (22277)
2012 (23661)
2011 (23921)
2010 (22154)
Location
Africa (807)
Arizona (153)
Asia (36633)
Australia (6378)
California (3609)
Canada (1250)
China (287)
Colorado (159)
Connecticut (185)
Europe (86745)
Florida (503)
Georgia (120)
Illinois (342)
Indiana (198)
Maryland (622)
Massachusetts (2870)
Michigan (141)
Minnesota (269)
New Jersey (1040)
New York (1022)
North Carolina (759)
Northern California (1616)
Ohio (131)
Pennsylvania (857)
South America (1160)
Southern California (1374)
Texas (502)
Utah (104)
Washington State (382)
613,992 Results for "parkinson s disease foundation".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Neurodegenerative disease
7 Alzheimer’s and Parkinson’s Programs Discarded in 2024
This year has seen several biopharma companies drop Alzheimer’s and Parkinson’s disease programs, but experts say plenty are still chasing these multi-billion-dollar markets.
November 4, 2024
·
6 min read
·
Heather McKenzie
Business
MilliporeSigma and The Michael J. Fox Foundation Offer Service to Advance Parkinson’s Research
MilliporeSigma and The Michael J. Fox Foundation for Parkinson’s Research (MJFF), are advancing research aimed at slowing progression of Parkinson’s disease (PD).
June 18, 2024
·
4 min read
Press Releases
Gain Therapeutics to Present at Michael J. Fox Foundation’s 16th Annual Parkinson’s Disease Therapeutics Conference
October 9, 2024
·
5 min read
Press Releases
NeuroDex Inc. Receives Grant from The Michael J. Fox Foundation to Advance Biomarker Research for Parkinson’s Disease
November 13, 2024
·
1 min read
Pharm Country
Kannalife Secures Funding of $1.49 Million from The Michael J. Fox Foundation for Parkinson’s Research
Kannalife Sciences, Inc. is pleased to announce it has been awarded funding of $1,493,409 million from The Michael J. Fox Foundation for Parkinson’s Research.
June 25, 2024
·
4 min read
Parkinson’s disease
Breaking the Cycle of Inflammation in Parkinson’s Disease
Halia Therapeutics, NodThera and Gain Therapeutics target neuroinflammatory processes in hopes of modifying the course of Parkinson’s progression.
July 15, 2024
·
4 min read
·
Jill Drachenberg
Press Releases
7 Most Promising Drugs in Parkinson’s Disease Treatment Pipeline
December 10, 2024
·
1 min read
Parkinson’s disease
AbbVie’s $8.7B Cerevel Buy Starts to Pay off With Phase III Parkinson’s Win
Results from TEMPO-1, which showed that tavapadon significantly improved motor symptoms in patients with Parkinson’s disease, will help AbbVie as it builds a regulatory case for the D1/D5 dopamine receptor agonist.
September 27, 2024
·
2 min read
·
Tristan Manalac
Spur Therapeutics Presents Promising New Data from its GBA1 Parkinson’s Disease Research Program
Spur Therapeutics, formerly Freeline Therapeutics, today announced new data from its GBA1 Parkinson’s disease research program demonstrating that its rationally engineered GCase85 enzyme reduces the accumulation of α-Synuclein, a protein that plays a significant role in the development and progression of Parkinson’s disease, more effectively than wildtype glucocerebrosidase (GCase) in in vitro studies.
July 1, 2024
·
5 min read
Press Releases
Spur Therapeutics Announces Development Candidate in Parkinson’s Disease Gene Therapy Program
December 4, 2024
·
5 min read
1 of 61,400
Next
